DC
Debjit Chattopadhyay Guggenheim Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Soleno Therapeutics
SLNO
$3.7B
| $69.57 | $106 |
52%
upside
| Buy | 8 days ago |
|
2
BioMarin Pharmaceuticals
BMRN
$10.9B
| $56.75 | $106 |
87%
upside
| Buy | 29 days ago |
|
3
Vertex Pharmaceuticals
VRTX
$102B
| $396.93 | $546 |
38%
upside
| Buy | 29 days ago |
|
4
Ultragenyx Pharmaceutical
RARE
$3.01B
| $31.28 | $64 |
105%
upside
| Buy | 2 months ago |
|
5
Dyne Therapeutics
DYN
$1.88B
| $13.24 | $50 |
278%
upside
| Buy | 2 months ago |
|
6
uniQure
QURE
$973M
| $17.73 | $28 |
58%
upside
| Buy | 3 months ago |
|
7
Intellia Therapeutics
NTLA
$1.25B
| $11.62 | $45 |
287%
upside
| Buy | 3 months ago |
|
8
Krystal Biotech
KRYS
$4.33B
| $149.75 | $189 |
26%
upside
| Buy | 4 months ago |
|
9
Beam Therapeutics
BEAM
$1.88B
| $18.54 | $55 |
197%
upside
| Buy | 4 months ago |
|
10
Sarepta Therapeutics
SRPT
$1.93B
| $18.46 | $98 |
431%
upside
| Buy | 4 months ago |
|
11
Ionis Pharmaceuticals
IONS
$9.46B
| $59.35 | $64 |
8%
upside
| Buy | 4 months ago |
|
|
MAZE
12
Maze Therapeutics, Inc. Common Stock
MAZE
$660M
| $15.04 | $19 |
26%
upside
| Buy | 5 months ago |
|
|
CNTA
13
Centessa Pharmaceuticals
CNTA
$2.12B
| $15.79 | $28 |
77%
upside
| Buy | 5 months ago |
|
14
Prime Medicine
PRME
$606M
| $3.40 | $18 |
429%
upside
| Buy | 9 months ago |
|
15
Benitec Biopharma
BNTC
$368M
| $14 | $17 |
21%
upside
| Buy | 9 months ago |
|
16
Amicus Therapeutics
FOLD
$2.47B
| $8.02 | $15 |
87%
upside
| Buy | 10 months ago |
|
17
NewAmsterdam Pharma
NAMS
$2.89B
| $25.66 | $30 |
17%
upside
| Buy | 1 year ago |
|
18
Taysha Gene Therapies
TSHA
$889M
| $3.26 | $28 |
759%
upside
| Buy | 3 years ago |
|
19
Wave Life Sciences
WVE
$1.3B
| $8.18 | $20 |
145%
upside
| Buy | 4 years ago |
|
|
20
Sarepta Therapeutics
SRPT
$1.93B
| $18.46 | $221 |
1,097%
upside
| Buy | 5 years ago |
|
21
Galapagos
GLPG
$2.1B
| $31.91 | $123 |
285%
upside
| Neutral | 5 years ago |
|
22
Zymeworks
ZYME
$1.07B
| $14.08 | $54 |
284%
upside
| Buy | 5 years ago |
|
|
23
uniQure
QURE
$973M
| $17.73 | $64 |
261%
upside
| Buy | 5 years ago |
|